{"text_format":"2","workbook":"xls","n_sheets":2,"sheets":["Sheet1","Sheet2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":29,"n_cols":3,"rows_kept":29,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}
["Table S1. The number of DEGs of all cancer datasets."]
["Cancer Type","UpRegulatedGene","DownRegulatedGene"]
["Lung adenocarcinoma",432,643]
["Squamous cell lung carcinoma",188,408]
["Breast carcinoma",376,1125]
["Malignant pleural mesothelioma",926,924]
["Hepatocellular carcinoma, advanced  stage",1471,776]
["Hepatocellular carcinoma, early stage",761,544]
["Liver cirrhosis",617,130]
["Dysplastic liver",339,193]
["Astrocytoma",1464,1342]
["Glioblastoma",1898,1744]
["Oligodendroglioma",1309,1426]
["Prostate carcinoma",177,456]
["T-cell lymphoma",605,2290]
["Mucinous ovarian cancer",243,213]
["Serous ovarian cancer",193,250]
["Clear cell ovarian cancer",238,307]
["Endometrioid ovarian cancer",153,238]
["Smoldering myeloma",2134,2409]
["Colorectal adenoma",1061,1723]
["Urinary bladder cancer",2018,413]
["Urinary bladder cancer, low grade",593,988]
["Urinary bladder cancer, high grade invasive",118,895]
["Papillary renal carcinoma",361,633]
["Renal cell carcinoma(1)",762,550]
["Renal cell carcinoma(2)",367,472]
["Papillary thyroid cancer(1)",367,558]
["Papillary thyroid cancer(2)",63,69]

{"sheet":"Sheet2","index":1,"n_rows":27,"n_cols":3,"rows_kept":27,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}
["Lung adenocarcinoma",432,643]
["Squamous cell lung carcinoma",188,408]
["Breast carcinoma",376,1125]
["Malignant pleural mesothelioma",926,924]
["Hepatocellular carcinoma, advanced  stage",1471,776]
["Hepatocellular carcinoma, early stage",761,544]
["Liver cirrhosis",617,130]
["Dysplastic liver",339,193]
["Astrocytoma",1464,1342]
["Glioblastoma",1898,1744]
["Oligodendroglioma",1309,1426]
["Prostate carcinoma",177,456]
["T-cell lymphoma",605,2290]
["Mucinous ovarian cancer",243,213]
["Serous ovarian cancer",193,250]
["Clear cell ovarian cancer",238,307]
["Endometiroid ovarian cancer",153,238]
["Smoldering myeloma",2134,2409]
["Colorectal adenoma",1061,1723]
["Urinary bladder cancer",2018,413]
["Urinary bladder cancer, low grade",593,988]
["Urinary bladder cancer, high grade invasive",118,895]
["Papillary renal carcinoma",361,633]
["Renal cell carcinoma(1)",762,550]
["Renal cell carcinoma(2)",367,472]
["Papillary thyroid cancer(1)",367,558]
["Papillary thyroid cancer(2)",63,69]